Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States.
Samaneh KaliraiJasmina I IvanovaMagaly Perez-NievesJudith J StephensonIrene HadjiyianniMichael GrabnerRoy Daniel PollomCaroline GeremakisBeverly L ReedLawrence FisherPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2020)
Benefits of basal insulin therapy motivated continuers while side effects impacted interruption/discontinuation. Persistence on basal insulin is often influenced by provider actions. Earlier provider intervention upon signs of treatment discontinuation may promote persistence.